Nyang’wa, B. T. et al. A 24-week, all-oral regimen for rifampin-resistant tuberculosis. N. Engl. J. Med. 387, 2331–2343 (2022).
Mase, S. R. & Chorba, T. Treatment of drug-resistant tuberculosis. Clin. Chest Med. 40, 775–795 (2019).
Dartois, V. & Rubi…
Divergent transcriptional regulation of redox-homeostasis and permeability modulate rifampicin tolerance and sensitivity in Mycobacterium tuberculosis
